Hemispherx BioPharma Inc. (HEB) Fundamentals

Hemispherx Biopharma Inc is a US-based specialty pharmaceutical company. It is engaged in the clinical development of drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune-based disorders. The products of the firm are Alferon N Injection and the experimental therapeutic Ampligen. Alferon N Injection is approved for a category of STD infection, and Ampligen represents a RNA being developed for viral diseases and disorders of the immune system. The sales revenue of the company is derived from the United States.
SHARE INFORMATION
Market Cap$ 4,395,652
Shares Outstanding2,442,029
Float-
Percent Float0.0%
Short Interest120,646.00
Short Percent Float5.2%
Short Interest Ratio0.84
Short Interest Date2019-08-15
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 367,000
Latest Fiscal EPS$ -9.86
Latest Fiscal Date2018-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions26
Institutional Holdings Date2019-07-31
Institutional Bought Previous 3 Months114,292
Institutional Holdings Percent0.9%
Institutional Sold Previous 3 Months74,834
Insider Holdings Date2019-07-31
Insider Bought Previous 3 Months876,726
Insider Holdings Percent0.0
Insider Sold Previous 3 Months-
Insider Shares Owned4,008,023
TRADING INFO
52 Week High$ 14.81
52 Week Low$ 1.69
52 Week High Change$ -85.75
21 Day Moving Average$ 1.9463
21 Day Extended Moving Average$ 2.0947
50 Day Moving Average$ 2.9593
50 Day Extended Moving Average$ 2.9406
200 Day Moving Average$ 6.6733
200 Day Extended Moving Average$ 6.3472
10 Day Average Volume35,217
20 Day Average Volume112,046
30 Day Average Volume111,086
50 Day Average Volume121,989
Alpha-0.059192
Beta0.8706
Standard Deviation0.184165
R20.026604
7 Day Price Change$ -0.13
7 Day Percent Change-6.74%
21 Day Price Change$ -0.19
21 Day Percent Change-9.55%
30 Day Price Change$ -0.82
30 Day Percent Change-31.3%
Month to Date Price Change$ -0.55
Month to Date Percent Change-23.4%
Quarter to Date Price Change$ -2.59
Quarter to Date Percent Change-59.0%
180 Day Price Change$ -6.12
180 Day Percent Change-77.27%
200 Day Price Change$ -8.76
200 Day Percent Change-82.95%
Year to Date Price Change$ -6.16
Year to Date Percent Change-77.4%

Hemispherx BioPharma Inc. (HEB) Key Ratios

PROFITABILITY
EBIT Margin-3,071.7%
EBITDA Margin-2,804.9%
Pre-Tax Profit Margin-6,605.4%
Profit Margin Count0.0%
Gross Margin-204.9%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 307,000
Revenue Per Share$ 0.1257
Revenue (3 Years)$ 50.83
Revenue (5 Years)$ 18.35
FINANCIAL STRENGTH
Price to Tangible Book1.10
Total Debt To Equity0.90
Int Coverage-14.50
Current Ratio2.10
Leverage Ratio3.20
Quick Ratio1.70
Long Term Debt To Capital0.41
VALUATION MEASURES
PE Ratio0.00
Enterprise Value$ 7,786,173
Price to Sales14.3181
Price to Free Cash-0.50
PE High Last 5 Years0.00
Price To Book0.90
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book1.10
MANAGEMENT EFFECTIVENESS
Receivables Turnover3.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-68.37
Return on Equity-139.80
Return on Capital-86.21

Hemispherx BioPharma Inc. (HEB) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorMorrison, Brown, Argiz & Farra, LLC
CEOThomas K. Equels
Emplyoees33
Last AuditUQ
CIK0000946644
IndustryBiotechnology
SectorHealthcare
NAICSBiological Product (except Diagnostic) Manufacturing(325414)
CONTACT INFO
Address2117 SW Highway 484
Suite B
Ocala, FL 34473
Websitehttps://www.hemispherx.net
Facsimile+1 305 839-2050
Telephone+1 215 988-0080
Emailinfo@hemispherx.net


Your Recent History
AMEX
HEB
Hemispherx..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.